Woodworth, Kate R;
Moulia, Danielle;
Collins, Jennifer P;
Hadler, Stephen C;
Jones, Jefferson M;
Reddy, Sujan C;
Chamberland, Mary;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Brooks, Oliver;
Talbot, H. Keipp;
Lee, Grace M;
Bell, Beth P;
Daley, Matthew F;
Mbaeyi, Sarah;
Dooling, Kathleen;
Oliver, Sara E.
The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle–formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. On August 23, 2021, the Food and Drug Administration (FDA) approved a Biologics License Applicati...
Fleming-Dutra, Katherine E;
Wallace, Megan;
Moulia, Danielle L;
Twentyman, Evelyn;
Roper, Lauren E;
Hall, Elisha;
Link-Gelles, Ruth;
Godfrey, Monica;
Woodworth, Kate R;
Anderson, Tara C;
Rubis, Amy B;
Shanley, Edwin;
Jones, Jefferson M;
Morgan, Rebecca L;
Brooks, H. Oliver;
Talbot, Keipp;
Lee, Grace M;
Bell, Beth P;
Meyer, Sarah;
Daley, Matthew;
Oliver, Sara E.
On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months–5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks apart, and BNT162b2 (Pfizer-BioNTech) COVID-19 va...
Wallace, Megan;
Moulia, Danielle;
Blain, Amy E;
Ricketts, Erin K;
Minhaj, Faisal S;
Link-Gelles, Ruth;
Curran, Kathryn G;
Hadler, Stephen C;
!Asif, Amimah;
Godfrey, Monica;
Hall, Elisha;
Fiore, Anthony;
Meyer, Sarah;
Su, John R;
Weintraub, Eric;
Oster, Matthew E;
Shimabukuro, Tom T;
Campos-Outcalt, Doug;
Morgan, Rebecca L;
Bell, Beth P;
Brooks, Oliver;
Talbot, H. Keipp;
Lee, Grace M;
Daley, Matthew F;
Oliver, Sara E.
The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine was granted Emergency Use Authorization (EUA) by the Food a...
Oliver, Sara E;
Wallace, Megan;
See, Isaac;
Mbaeyi, Sarah;
Godfrey, Monica;
Hadler, Stephen C;
Jatlaoui, Tara C;
Twentyman, Evelyn;
Hughes, Michelle M;
Rao, Agam K;
Fiore, Anthony;
Su, John R;
Broder, Karen R;
Shimabukuro, Tom;
Lale, Allison;
Shay, David K;
Markowitz, Lauri E;
Wharton, Melinda;
Bell, Beth P;
Brooks, Oliver;
McNally, Veronica;
Lee, Grace M;
Talbot, H. Keipp;
Daley, Matthew F.
On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson), and on February 28, 2021, the Advisory Committee on Immunization Practices (A...
Chronic pain patients require continuity of care even during the COVID-19 pandemic, which has drastically changed healthcare and other societal practices. The American Society of Interventional Pain Physicians (ASIPP) has created the COVID-ASIPP Risk Mitigation and Stratification (COVID-ARMS) Return to P...
Infecciones por Coronavirus/complicaciones,
Betacoronavirus,
Factores de Riesgo,
Enfermedades Cardiovasculares/complicaciones,
Hipertensión,
Diabetes Mellitus,
Obesidad,
Esteroides,
Manejo del Dolor,
Enfermedad Crónica,
Neumonía Viral/complicaciones
Chiappini, Elena;
Ciarcià, Martina;
Bortone, Barbara;
Doria, Mattia;
Becherucci, Paolo;
Marseglia, Gian Luigi;
Motisi, Marco Antonio;
de Martino, Maurizio;
Galli, Luisa;
Licari, Amelia;
De Masi, Salvatore;
Lubrano, Riccardo;
Bettinelli, Maria;
Vicini, Claudio;
Felisati, Giovanni;
Villani, Alberto;
Marchisio, Paola.
In recent years, new progress has been made regarding the diagnosis, treatment and prevention of acute otitis media (AOM). The Italian Pediatric Society therefore decided to issue an update to the previous guidelines published in 2010. Literature searches were conducted on MEDLINE by Pubmed, including st...
Marchisio, Paola;
Bortone, Barbara;
Ciarcià, Martina;
Motisi, Marco Antonio;
Torretta, Sara;
Castelli Gattinara, Guido;
Picca, Marina;
Di Mauro, Giuseppe;
Bonino, Marisa Nurse;
Mansi, Nicola;
Varricchio, Alfonso;
Marseglia, Gian Luigi;
Cardinale, Fabio;
Villani, Alberto;
Chiappini, Elena.
In recent years, new information has been acquired regarding the diagnosis, treatment and prevention of acute otitis media (AOM). The Italian Pediatric Society, therefore, decided to issue an update to the Italian Pediatric Society guidelines published in 2010. The search was conducted on Pubmed, and onl...
Marchisio, Paola;
Galli, Luisa;
Bortone, Barbara;
Ciarcià, Martina;
Antonio Motisi, Marco;
Novelli, Andrea;
Pinto, Luciano;
Bottero, Sergio;
Pignataro, Lorenzo;
Piacentini, Giorgio;
Mattina, Roberto;
Cutrera, Renato;
Varicchio, Attilio;
Luigi Marseglia, Gian;
Villani, Alberto;
Chiappini, Elena.
New insights into the diagnosis, treatment and prevention of acute otitis media (AOM) have been gained in recent years. For this reason, the Italian Paediatric Society has updated its 2010 guidelines. A literature search was carried out on PubMed. Only pediatric studies published between January 1, 2010 ...
Buxbaum, James L;
Fehmi, Syed M. Abbas;
Sulta, Shahnaz;
Fishman, Douglas S;
Qumseya, Bashar J;
Cortessis, Victoria K;
Schilperoort, Hannah;
Kysh, Lynn;
Matsuoka, Lea;
Yachimsk, Patrick;
Agrawal, Deepak;
Gurudu, Suryakanth R;
Jamil, Laith H;
Jue, Terry L;
Khashab, Mouen A;
Law, Joanna K;
Lee, Jeffrey K;
Naveed, Mariam;
Sawhney, Mandeep S;
Thosani, Nirav;
Yang, Julie;
Wani, Sachin B.
Each year choledocholithiasis results in biliary obstruction, cholangitis, and pancreatitis in a significant number of patients. The primary treatment, ERCP, is minimally invasive but associated with adverse events in 6% to 15%. This American Society for Gastrointestinal Endoscopy (ASGE) Standard of Prac...
Tacconelli, E;
Mazzaferri, F;
Smet, A.M. de;
Bragantini, D;
Eggimann, P;
Huttner, B. D;
Kuijper, E. J;
Lucet, J. C;
Mutters, N. T;
Sanguinetti, M;
Schwaber, M. J;
Souli, M;
Torre-Cisneros, J;
Price, J. R;
Rodríguez-Bano, J.
The aim of these guidelines is to provide recommendations for decolonizing regimens targeting
multidrug-resistant Gram-negative bacteria (MDR-GNB) carriers in all settings.
Methods: These evidence-based guidelines were produced after a systematic review of published studies
on decolonization intervention...
Infecciones por Bacterias Gramnegativas/diagnóstico,
Infecciones por Bacterias Gramnegativas/prevención & control,
Infecciones por Bacterias Gramnegativas/transmisión,
Política Informada por la Evidencia,
Infecciones por Enterobacteriaceae/prevención & control,
Infecciones por Enterobacteriaceae/transmisión,
Infecciones por Enterobacteriaceae/diagnóstico,
Resistencia a las Cefalosporinas/efectos de los fármacos,
Cefalosporinas/uso terapéutico,
Aminoglicósidos/uso terapéutico,
Fluoroquinolonas/uso terapéutico,
Trasplante de Microbiota Fecal/instrumentación
